/ICLR
ICON Public Limited Company
ICLR • NASDAQICLR • NASDAQ • Healthcare
$97.83-2.65%-2.66
$97.83-2.65%(-2.66)Healthcare
GoAI Score
Sign in to unlock
Valuation
50Fair Value
Sentiment
100Bullish
Risk
66Low Risk
Momentum
5Negative
Institutional-Grade Intelligence
🏆PRO
Actionable Intelligence
AI-driven stance, execution logic & risk thresholds
Catalyst Roadmap
Event timeline with expected impact & market context
Deep Insights
Fact-checked analysis & score logic breakdown
Financial Statements
Margin Trends
Gross
29.4%▼0.1pp
Revenue after COGS
Operating
13.3%▲1.5pp
After operating expenses
Net
9.6%▲2.0pp
Bottom-line profitability
Gross Margin
Operating Margin
Net Margin
Valuation Snapshot
P/E Ratio
21.9
Price vs earnings
EV/EBITDA
13.0
Enterprise value
FCF Yield
6.5%
Cash generation
Earnings Yield
4.6%
Inverse of P/E
Capital Efficiency
7
GoAI Quality ScoreWeak
ROEReturn on Equity
8.3%Fair
ROAReturn on Assets
4.7%Fair
ROICReturn on Invested Capital
7.1%Fair
Financial Health
Current RatioAdequate
1.26
Short-term solvency (>1.5)
Net Debt / EBITDAManageable
1.96x
Debt repayment capacity (<3x)
Income QualityStrong
1.63
Cash backs earnings (>1)
Revenue & Profitability
Revenue
Net Income
Net Loss
Income Statement
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $8.28B | $8.12B | $7.74B | $5.48B | $2.80B |
| Gross Profit | $2.44B | $2.40B | $2.21B | $1.51B | $808.03M |
| Gross Margin | 29.4% | 29.6% | 28.6% | 27.5% | 28.9% |
| Operating Income | $1.10B | $956.15M | $795.24M | $378.53M | $391.50M |
| Net Income | $791.47M | $612.34M | $505.30M | $153.19M | $327.81M |
| Net Margin | 9.6% | 7.5% | 6.5% | 2.8% | 11.7% |
| EPS | $9.60 | $7.46 | $6.20 | $2.28 | $6.29 |
Average Price Target
$157.44▲ 60.9% Upside
Past 12 Months
12 Month Forecast
Based on 50 Wall Street analysts offering 12 month price targets for ICON Public Limited Company, the average price target is $157.44, with a high forecast of $222.00 and a low forecast of $100.00. The average price target represents a 60.9% increase from the current price of $97.83.
Highest
$222.00
Average
$157.44
Lowest
$100.00
Rating Distribution
Strong Buy
0
0%
Buy
16
55%
Hold
12
41%
Sell
1
3%
Strong Sell
0
0%
Recent Analyst Ratings
FirmActionRatingDate
Citigroup● Maintain
Neutral
2026-03-11Barclays● Maintain
Equal Weight
2026-03-09Jefferies▲ Upgrade
Hold→Buy
2026-02-23TD Cowen▲ Upgrade
Hold→Buy
2026-02-18TD Cowen● Maintain
Hold
2026-01-22Truist Securities▼ Downgrade
Buy→Hold
2026-01-08Barclays● Maintain
Equal Weight
2025-12-15TD Cowen● Maintain
Hold
2025-10-24Barclays● Maintain
Equal Weight
2025-10-24Barclays● Maintain
Equal Weight
2025-10-02Earnings History & Surprises
BEAT RATE
83%
Last 18 quarters
AVG SURPRISE
+0.6%
EPS vs Estimate
BEATS / MISSES
15/2
1 met exactly
LATEST EPS
$3.31
Q4 '25
QUARTERLY EPS TREND
Estimated
Beat
Miss
QUARTERLY DETAIL
Q4 '25
+0.9%
$3.31 vs $3.28
Q3 '25
+2.2%
$3.26 vs $3.19
Q2 '25
+2.6%
$3.19 vs $3.11
Q1 '25
+0.6%
$3.43 vs $3.41
Q4 '24
-13.0%
$3.35 vs $3.85
Q3 '24
+1.9%
$3.75 vs $3.68
Q2 '24
+1.8%
$3.47 vs $3.41
Q1 '24
+0.6%
$3.46 vs $3.44
Q4 '23
+0.6%
$3.30 vs $3.28
Q3 '23
+1.0%
$3.11 vs $3.08
Q2 '23
-2.7%
$2.90 vs $2.98
Q1 '23
+2.3%
$3.13 vs $3.06
No investor questions available.
Latest News
No news available